Dr. Arda M. Minocherhomjee, PhD. is the Managing Partner at Chicago Growth Partners. Dr. Minocherhomjee serves as a Venture Partner at Jungle Ventures. He focuses on the healthcare sector. He was an Equity Analyst at RBS Research. He served as an Equity Analyst at Ragen Mackenzie Group, Inc., Research Division and William Blair & Company L.L.C., Research Division. Dr. Minocherhomjee was a Managing Director of William Blair Capital Partners LLC (WBCP) since September 1998. He joined William Blair & Co. as a Senior Healthcare Analyst on 1992 and as the Head of the Healthcare Research Group, he covered several sectors, including drugs and drug delivery, medical devices and selected healthcare services. He serves as a Director at Pharma Research Corp., Cubic Wafer, Inc., Cypress Medical Products Inc. and NovaVision Inc. He has been a Director of EndoGastric Solutions, Inc. since February 2006. Dr. Minocherhomjee is a Member of Board at Xoft, Inc. He serves on the Boards of several privately held pharmaceutical and medical device companies. He served as a Director of Favrille Inc. since March 2004 until June 21, 2007. He served as a Caprion Proteomics, Inc. and Director of Inhibitex Inc. since June 2000 until May 17, 2005. Dr. Minocherhomjee served as a Director of NuVasive Inc., since May 2001 until September 5, 2005. He served as a Director at Genoptix Inc. since July 2005 until January 6, 2009. He served as a Director of CryoCor Inc. since June 2003. He served as a Director of TargeGen Inc. He served as a Director of Zogenix, Inc. from December 2009 to February 1, 2013. Dr. Minocherhomjee was a Director at Actavis Mid-Atlantic, LLC, Zycos Inc., Atherogenics, Inc., DJ Pharma, Inc., Morton Grove Pharmaceuticals Inc., MGI Pharma Biologics, Inc., and Proteome, Inc. Some of his other current and past Directorships include: Advanced Pain Management and Zogenix. He was a Director of Lanx, Inc. He served as a Director of POINT Biomedical Corp. since 2002. He was a Wall Street Journal 'All-Star Analyst' in both medical device and pharmaceutical sectors. Dr. Minocherhomjee was a post-doctoral fellow in Pharmacology at University of Washington Medical School and holds a Ph.D. and an M.B.A. from University of British Columbia and an M.S. in Pharmacology from the University of Toronto.